Back to results
US 2020/0206244 A1Published application
Treatment of demyelinating diseases
AssigneeM Et P Pharma AG
InventorsClaudia MATTERN, Elisabeth TRAIFFORT, Michael SCHUMACHER
Life of this patent
Estimating the term…
Abstract
Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
Claims14
1-16. (canceled)
A method of reducing inflammation in the brain in a subject in need thereof, comprising administering to the subject a Smoothened (Smo) agonist.
Dependencies are inferred from the claim text.